Search - tctmd.com

Displaying 701 - 720 of 1243

Sort: Relevancy | Date

Presentation TCT 2019

TAVR With High Risk for Coronary Obstruction (Low Coronaries and Effaced Sinuses): Case Presentation and Management Strategies — How to Protect the Coronaries, BASILICA, etc.

Presenter: John Forrest

September 26, 2019

Presentation TCT 2019

Case Presentation

Presenter: Steven Yakubov

September 26, 2019

Presentation TCT 2019

A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR

Presenter: Davide Capodanno

September 26, 2019

Presentation TCT 2019

Remaining Data Gaps After the Low-Risk TAVR RCTs

Presenter: Michael Borger

September 26, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Presenter: Michael Reardon

September 26, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the PARTNER 3 Trial

Presenter: Martin Leon

September 26, 2019

Presentation TCT 2019

Case Presentation: Low-Risk AS

Presenter: Amisha Patel

September 26, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

Presentation TCT 2019

COAPT, Partner 2, and Evolut Low-Risk Trial Synopsis and What They Mean Moving Forward

Presenter: Elizabeth Perpetua

September 25, 2019

Presentation TCT 2019

The Clinical Evidence: Extreme- to Low-Risk Patients

Presenter: Michael Reardon

September 25, 2019

News Daily News

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Yael L. Maxwell

September 18, 2019

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Todd Neale

September 11, 2019

News Conference News ESC 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

Todd Neale

September 10, 2019

News Conference News ESC 2019

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

L.A. McKeown

September 05, 2019

News Daily News

VA Medical Centers’ Quality Measures for TAVR Pay Off

Caitlin E. Cox

August 30, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

Shelley Wood

August 30, 2019

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

News Daily News

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Caitlin E. Cox

August 27, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

News Daily News

Expert Consensus Gives Initial Guidance on Post-TAVR Conduction Disturbances

Yael L. Maxwell

August 20, 2019

Advertisement

TAVR With High Risk for Coronary Obstruction (Low Coronaries and Effaced Sinuses): Case Presentation and Management Strategies — How to Protect the Coronaries, BASILICA, etc.

Case Presentation

A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR

Remaining Data Gaps After the Low-Risk TAVR RCTs

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Deep-Dive: NEW Insights From the PARTNER 3 Trial

Case Presentation: Low-Risk AS

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

COAPT, Partner 2, and Evolut Low-Risk Trial Synopsis and What They Mean Moving Forward

The Clinical Evidence: Extreme- to Low-Risk Patients

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

VA Medical Centers’ Quality Measures for TAVR Pay Off

TCTMD’s Top 10 Most Popular Stories for August 2019

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Expert Consensus Gives Initial Guidance on Post-TAVR Conduction Disturbances

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content